v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues
Operating expenses:        
Research and development 1,245,530 1,943,746 4,240,445 4,734,020
General and administrative 1,372,026 1,283,721 4,594,318 4,279,223
Total operating expenses 2,617,556 3,227,467 8,834,763 9,013,243
Operating loss (2,617,556) (3,227,467) (8,834,763) (9,013,243)
Other income (expense):        
Interest income 872 66,693 38,064 248,586
Interest expense (78,691) (78,690) (234,364) (233,508)
Equity modification expense (489,645) (2,290,688)
Amortization of debt discount and offering costs (51,899) (109,963) (235,260) (329,888)
Total other expense (619,363) (121,960) (2,722,248) (314,810)
Net loss $ (3,236,919) $ (3,349,427) $ (11,557,011) $ (9,328,053)
Basic and diluted net loss per share $ (0.06) $ (0.08) $ (0.25) $ (0.22)
Weighted average common shares outstanding - basic and diluted 50,201,985 42,861,422 45,569,737 42,766,300

Source